메뉴 건너뛰기




Volumn 66, Issue 9, 2010, Pages 957-958

Response to "zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: Sex as differentiating factor"

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A; MIDAZOLAM; TESTOSTERONE; ZOLPIDEM;

EID: 77956192260     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0855-9     Document Type: Letter
Times cited : (2)

References (21)
  • 1
    • 11944274532 scopus 로고    scopus 로고
    • The influence of age and sex on the clearance of cytochrome P450 3A substrates
    • 10.2165/00003088-200544010-00002 1:CAS:528:DC%2BD2MXhsVeisLY%3D 15634031
    • MM Cotreau LL von Moltke DJ Greenblatt 2005 The influence of age and sex on the clearance of cytochrome P450 3A substrates Clin Pharmacokinet 44 33 60 10.2165/00003088-200544010-00002 1:CAS:528:DC%2BD2MXhsVeisLY%3D 15634031
    • (2005) Clin Pharmacokinet , vol.44 , pp. 33-60
    • Cotreau, M.M.1    Von Moltke, L.L.2    Greenblatt, D.J.3
  • 2
    • 54049096401 scopus 로고    scopus 로고
    • Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs
    • 10.1177/0091270008323754 1:CAS:528:DC%2BD1cXhtlyrs7bE 18757784
    • DJ Greenblatt LL von Moltke 2008 Gender has a small but statistically significant effect on clearance of CYP3A substrate drugs J Clin Pharmacol 48 1350 1355 10.1177/0091270008323754 1:CAS:528:DC%2BD1cXhtlyrs7bE 18757784
    • (2008) J Clin Pharmacol , vol.48 , pp. 1350-1355
    • Greenblatt, D.J.1    Von Moltke, L.L.2
  • 3
    • 66749088074 scopus 로고    scopus 로고
    • Sex differences of drug-metabolizing enzyme: Female predominant expression of human and mouse cytochrome P450 3A isoforms
    • 10.1248/jhs.55.325
    • T Sakuma Y Kawasaki K Jarukamjorn N Nemoto 2009 Sex differences of drug-metabolizing enzyme: female predominant expression of human and mouse cytochrome P450 3A isoforms J Health Sci 55 328 337 10.1248/jhs.55.325
    • (2009) J Health Sci , vol.55 , pp. 328-337
    • Sakuma, T.1    Kawasaki, Y.2    Jarukamjorn, K.3    Nemoto, N.4
  • 4
    • 65349137639 scopus 로고    scopus 로고
    • Sex differences in pharmacokinetics and pharmacodynamics
    • 10.2165/00003088-200948030-00001 1:CAS:528:DC%2BD1MXmtlant7g%3D 19385708
    • OP Soldin DR Mattison 2009 Sex differences in pharmacokinetics and pharmacodynamics Clin Pharmacokinet 48 143 157 10.2165/00003088-200948030-00001 1:CAS:528:DC%2BD1MXmtlant7g%3D 19385708
    • (2009) Clin Pharmacokinet , vol.48 , pp. 143-157
    • Soldin, O.P.1    Mattison, D.R.2
  • 5
    • 73449141860 scopus 로고    scopus 로고
    • Gender and interindividual variability in pharmacokinetics
    • 10.1080/10837450902891485 1:CAS:528:DC%2BD1MXosV2mtL4%3D 19601720
    • J Nicolas P Espie M Molimard 2009 Gender and interindividual variability in pharmacokinetics Drug Metab Rev 41 408 421 10.1080/10837450902891485 1:CAS:528:DC%2BD1MXosV2mtL4%3D 19601720
    • (2009) Drug Metab Rev , vol.41 , pp. 408-421
    • Nicolas, J.1    Espie, P.2    Molimard, M.3
  • 6
    • 1342302371 scopus 로고    scopus 로고
    • Sex differences in pharmacokinetics and pharmacodynamics
    • 10.1146/annurev.pharmtox.44.101802.121453 1:CAS:528:DC%2BD2cXhvVCktb8%3D 14744256
    • M Gandhi F Aweeka RM Greenblatt TF Blaschke 2004 Sex differences in pharmacokinetics and pharmacodynamics Annu Rev Pharmacol Toxicol 44 499 523 10.1146/annurev.pharmtox.44.101802.121453 1:CAS:528:DC%2BD2cXhvVCktb8%3D 14744256
    • (2004) Annu Rev Pharmacol Toxicol , vol.44 , pp. 499-523
    • Gandhi, M.1    Aweeka, F.2    Greenblatt, R.M.3    Blaschke, T.F.4
  • 7
    • 0037275143 scopus 로고    scopus 로고
    • The influence of sex on pharmacokinetics
    • 10.2165/00003088-200342020-00001 1:CAS:528:DC%2BD3sXhsFyntbs%3D 12537512
    • JB Schwartz 2003 The influence of sex on pharmacokinetics Clin Pharmacokinet 42 107 121 10.2165/00003088-200342020-00001 1:CAS:528: DC%2BD3sXhsFyntbs%3D 12537512
    • (2003) Clin Pharmacokinet , vol.42 , pp. 107-121
    • Schwartz, J.B.1
  • 8
    • 0034099053 scopus 로고    scopus 로고
    • Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: Evaluation of sex-dependent differences
    • 1:CAS:528:DC%2BD3cXkvFWgsb0%3D
    • DJ Greenblatt JS Harmatz LL von Moltke CE Wright AL Durol LM Harrel-Joseph RI Shader 2000 Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences Drug Metab Dispos 293 435 443 1:CAS:528:DC%2BD3cXkvFWgsb0%3D
    • (2000) Drug Metab Dispos , vol.293 , pp. 435-443
    • Greenblatt, D.J.1    Harmatz, J.S.2    Von Moltke, L.L.3    Wright, C.E.4    Durol, A.L.5    Harrel-Joseph, L.M.6    Shader, R.I.7
  • 9
    • 0042916560 scopus 로고    scopus 로고
    • Pharmacokinetic properties of zolpidem in elderly and young adults: Possible modulation by testosterone
    • 10.1046/j.0306-5251.2003.01852.x 1:CAS:528:DC%2BD3sXnvVSguro%3D 12919178
    • JO Olubodun HR Ochs LL von Moltke R Roubenoff LM Hesse JS Harmatz RI Shader DJ Greenblatt 2003 Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone Br J Clin Pharmacol 56 297 304 10.1046/j.0306-5251.2003.01852.x 1:CAS:528:DC%2BD3sXnvVSguro%3D 12919178
    • (2003) Br J Clin Pharmacol , vol.56 , pp. 297-304
    • Olubodun, J.O.1    Ochs, H.R.2    Von Moltke, L.L.3    Roubenoff, R.4    Hesse, L.M.5    Harmatz, J.S.6    Shader, R.I.7    Greenblatt, D.J.8
  • 10
    • 0029074925 scopus 로고
    • Clinical pharmacokinetics and pharmacodynamics of zolpidem: Therapeutic implications
    • 10.2165/00003088-199529030-00002 8521677
    • P Salvà J Costa 1995 Clinical pharmacokinetics and pharmacodynamics of zolpidem: therapeutic implications Clin Pharmacokinet 29 142 153 10.2165/00003088-199529030-00002 8521677
    • (1995) Clin Pharmacokinet , vol.29 , pp. 142-153
    • Salvà, P.1    Costa, J.2
  • 11
    • 1842866515 scopus 로고    scopus 로고
    • Quinidine and haloperidol as modifiers of CYP3A4 activity: Multisite kinetic model approach
    • 10.1124/dmd.30.12.1512 1:CAS:528:DC%2BD38XptVyisbY%3D 12433827
    • A Galetin SE Clarke JB Houston 2002 Quinidine and haloperidol as modifiers of CYP3A4 activity: multisite kinetic model approach Drug Metab Dispos 30 1512 1522 10.1124/dmd.30.12.1512 1:CAS:528:DC%2BD38XptVyisbY%3D 12433827
    • (2002) Drug Metab Dispos , vol.30 , pp. 1512-1522
    • Galetin, A.1    Clarke, S.E.2    Houston, J.B.3
  • 12
    • 0042357511 scopus 로고    scopus 로고
    • Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: Midazolam, testosterone, and nifedipine
    • 10.1124/dmd.31.9.1108 1:CAS:528:DC%2BD3sXmslKlurY%3D 12920166
    • A Galetin SE Clarke JB Houston 2003 Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipine Drug Metab Dispos 31 1108 1116 10.1124/dmd.31.9. 1108 1:CAS:528:DC%2BD3sXmslKlurY%3D 12920166
    • (2003) Drug Metab Dispos , vol.31 , pp. 1108-1116
    • Galetin, A.1    Clarke, S.E.2    Houston, J.B.3
  • 13
    • 0032735988 scopus 로고    scopus 로고
    • CYP3A4 drug interactions: Correlation of 10 in vitro probe substrates
    • 10.1046/j.1365-2125.1999.00073.x 1:CAS:528:DyaK1MXnvFSrtr8%3D 10594474
    • KE Kenworthy JC Bloomer SE Clarke JB Houston 1999 CYP3A4 drug interactions: correlation of 10 in vitro probe substrates Br J Clin Pharmacol 48 716 727 10.1046/j.1365-2125.1999.00073.x 1:CAS:528:DyaK1MXnvFSrtr8%3D 10594474
    • (1999) Br J Clin Pharmacol , vol.48 , pp. 716-727
    • Kenworthy, K.E.1    Bloomer, J.C.2    Clarke, S.E.3    Houston, J.B.4
  • 14
    • 0035193493 scopus 로고    scopus 로고
    • Multisite kinetic models for CYP3A4: Simultaneous activation and inhibition of diazepam and testosterone metabolism
    • 1:CAS:528:DC%2BD3MXovFKrtL4%3D 11717184
    • KE Kenworthy SE Clarke J Andrews JB Houston 2001 Multisite kinetic models for CYP3A4: simultaneous activation and inhibition of diazepam and testosterone metabolism Drug Metab Dispos 29 1644 1651 1:CAS:528:DC%2BD3MXovFKrtL4%3D 11717184
    • (2001) Drug Metab Dispos , vol.29 , pp. 1644-1651
    • Kenworthy, K.E.1    Clarke, S.E.2    Andrews, J.3    Houston, J.B.4
  • 15
    • 0034093628 scopus 로고    scopus 로고
    • Human cytochrome P-450 3A4: In vitro drug-drug interaction patterns are substrate-dependent
    • 1:CAS:528:DC%2BD3cXhsVOit78%3D 10681383
    • RW Wang DJ Newton N Liu WM Atkins AY Lu 2000 Human cytochrome P-450 3A4: in vitro drug-drug interaction patterns are substrate-dependent Drug Metab Dispos 28 360 366 1:CAS:528:DC%2BD3cXhsVOit78%3D 10681383
    • (2000) Drug Metab Dispos , vol.28 , pp. 360-366
    • Wang, R.W.1    Newton, D.J.2    Liu, N.3    Atkins, W.M.4    Lu, A.Y.5
  • 16
    • 77956183952 scopus 로고    scopus 로고
    • Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: Sex as differentiating factor
    • in press
    • Cubala WJ, Wiglusz M, Burkiewicz A, Galuszko-Wegielnil M (2010) Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as differentiating factor. Eur J Clin Pharmacol; in press
    • (2010) Eur J Clin Pharmacol
    • Cubala, W.J.1    Wiglusz, M.2    Burkiewicz, A.3    Galuszko-Wegielnil, M.4
  • 17
    • 77951916870 scopus 로고    scopus 로고
    • In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A
    • 10.1007/s00228-009-0760-2 1:CAS:528:DC%2BC3cXitVOgsbw%3D 20012430
    • TM Polasek JS Sadagopal DJ Elliot JO Miners 2010 In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A Eur J Clin Pharmacol 66 275 283 10.1007/s00228-009-0760-2 1:CAS:528:DC%2BC3cXitVOgsbw%3D 20012430
    • (2010) Eur J Clin Pharmacol , vol.66 , pp. 275-283
    • Polasek, T.M.1    Sadagopal, J.S.2    Elliot, D.J.3    Miners, J.O.4
  • 18
    • 39849099803 scopus 로고    scopus 로고
    • Zolpidem abuse, dependence and withdrawal syndrome: Sex as susceptibility factor for adverse effects
    • 10.1111/j.1365-2125.2007.03028.x 17875189
    • WJ Cubala J Landowski HM Wichowicz 2008 Zolpidem abuse, dependence and withdrawal syndrome: sex as susceptibility factor for adverse effects Br J Clin Pharmacol 65 444 445 10.1111/j.1365-2125.2007.03028.x 17875189
    • (2008) Br J Clin Pharmacol , vol.65 , pp. 444-445
    • Cubala, W.J.1    Landowski, J.2    Wichowicz, H.M.3
  • 19
    • 33846449874 scopus 로고    scopus 로고
    • Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions
    • 10.1124/dmd.106.012633 1:CAS:528:DC%2BD2sXhvVKrs7k%3D 17093004
    • RS Obach RL Walsky K Venkatakrishnan 2007 Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions Drug Metab Dispos 35 246 255 10.1124/dmd.106.012633 1:CAS:528:DC%2BD2sXhvVKrs7k%3D 17093004
    • (2007) Drug Metab Dispos , vol.35 , pp. 246-255
    • Obach, R.S.1    Walsky, R.L.2    Venkatakrishnan, K.3
  • 20
    • 77549084821 scopus 로고    scopus 로고
    • Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut-The effect of diltiazem on the time-course of exposure to triazolam
    • 10.1016/j.ejps.2009.12.002 1:CAS:528:DC%2BC3cXjtVWksbs%3D 20025966
    • K Rowland Yeo M Jamei J Yang GT Tucker A Rostami-Hodjegan 2010 Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut-the effect of diltiazem on the time-course of exposure to triazolam Eur J Pharm Sci 39 298 309 10.1016/j.ejps.2009.12.002 1:CAS:528:DC%2BC3cXjtVWksbs%3D 20025966
    • (2010) Eur J Pharm Sci , vol.39 , pp. 298-309
    • Rowland Yeo, K.1    Jamei, M.2    Yang, J.3    Tucker, G.T.4    Rostami-Hodjegan, A.5
  • 21
    • 34548283499 scopus 로고    scopus 로고
    • In vitro approaches to investigate mechanism-based inactivation of CYP enzymes
    • 10.1517/17425255.3.3.321 1:CAS:528:DC%2BD2sXlvFaktrY%3D 17539741
    • TM Polasek JO Miners 2007 In vitro approaches to investigate mechanism-based inactivation of CYP enzymes Expert Opin Drug Metab Toxicol 3 321 329 10.1517/17425255.3.3.321 1:CAS:528:DC%2BD2sXlvFaktrY%3D 17539741
    • (2007) Expert Opin Drug Metab Toxicol , vol.3 , pp. 321-329
    • Polasek, T.M.1    Miners, J.O.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.